Renal Dialysis — Impact of Nurses´ Solution-focused Communication on the Fluid Adherence of Adult Patients on Hemodialysis
Citation(s)
Baines LS, Jindal RM Non-compliance in patients receiving haemodialysis: an in-depth review. Nephron. 2000 May;85(1):1-7. Review.
Bowles N, Mackintosh C, Torn A Nurses' communication skills: an evaluation of the impact of solution-focused communication training. J Adv Nurs. 2001 Nov;36(3):347-54.
Idier L, Untas A, Koleck M, Chauveau P, Rascle N Assessment and effects of Therapeutic Patient Education for patients in hemodialysis: a systematic review. Int J Nurs Stud. 2011 Dec;48(12):1570-86. doi: 10.1016/j.ijnurstu.2011.08.006. Epub 2011 Sep 14. Review.
Kugler C, Maeding I, Russell CL Non-adherence in patients on chronic hemodialysis: an international comparison study. J Nephrol. 2011 May-Jun;24(3):366-75. doi: 10.5301/JN.2010.5823.
Matteson ML, Russell C Interventions to improve hemodialysis adherence: a systematic review of randomized-controlled trials. Hemodial Int. 2010 Oct;14(4):370-82. doi: 10.1111/j.1542-4758.2010.00462.x. Epub 2010 Aug 27. Review.
McAllister M Doing practice differently: solution-focused nursing. J Adv Nurs. 2003 Mar;41(6):528-35.
McGee D, Del Vento A, Bavelas JB An interactional model of questions as therapeutic interventions. J Marital Fam Ther. 2005 Oct;31(4):371-84.
Morgan L A decade review: methods to improve adherence to the treatment regimen among hemodialysis patients. Nephrol Nurs J. 2000 Jun;27(3):299-304. Review.
Impact of Nurses´ Solution-focused Communication on the Fluid Adherence of Adult Patients on Hemodialysis
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
